News|Articles|November 10, 2025
FDA Action Update, October 2025: Clearance, Acceptance, and Extension
Author(s)Isabella Ciccone, MPH
Fact checked by: Kelly King
Catch up on any of the neurology news headlines you may have missed in October 2025, compiled into 1 place by the NeurologyLive® team.
Advertisement
Advertisement
The FDA was busy in October 2025, making a number of decisions on potential new therapeutic agents, including accepting a new drug application, granting a fast track designation, giving a clearance, and extending a review period.
Advertisement
Advertisement